ANGO Angiodynamics Inc

Price (delayed)

$27.53

Market cap

$1.06B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.82

Enterprise value

$1.03B

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include ...

Highlights
Angiodynamics's EPS has soared by 82% from the previous quarter and by 81% YoY
ANGO's net income has surged by 81% since the previous quarter and by 81% year-on-year
The quick ratio has decreased by 17% QoQ and by 13% YoY
The gross margin has decreased by 5% YoY

Key stats

What are the main financial stats of ANGO
Market
Shares outstanding
38.44M
Market cap
$1.06B
Enterprise value
$1.03B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.39
Price to sales (P/S)
3.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.54
Earnings
Revenue
$291.01M
EBIT
-$35.19M
EBITDA
-$6.82M
Free cash flow
$10.38M
Per share
EPS
-$0.82
Free cash flow per share
$0.27
Book value per share
$11.52
Revenue per share
$7.59
TBVPS
$4.99
Balance sheet
Total assets
$561.44M
Total liabilities
$121.98M
Debt
$20M
Equity
$439.46M
Working capital
$83.3M
Liquidity
Debt to equity
0.05
Current ratio
2.45
Quick ratio
1.45
Net debt/EBITDA
4.13
Margins
EBITDA margin
-2.3%
Gross margin
53.9%
Net margin
-10.8%
Operating margin
-12.1%
Efficiency
Return on assets
-5.4%
Return on equity
-7%
Return on invested capital
-28.2%
Return on capital employed
-7%
Return on sales
-12.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
2.27%
1 week
3.89%
1 month
2.84%
1 year
202.86%
YTD
79.58%
QTD
1.47%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$291.01M
Gross profit
$156.79M
Operating income
-$35.1M
Net income
-$31.55M
Gross margin
53.9%
Net margin
-10.8%
The company's net margin has surged by 83% YoY and by 83% QoQ
The company's operating margin has surged by 82% YoY and by 82% QoQ
ANGO's operating income has soared by 81% since the previous quarter and by 80% year-on-year
ANGO's net income has surged by 81% since the previous quarter and by 81% year-on-year

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
2.39
P/S
3.63
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.54
Angiodynamics's EPS has soared by 82% from the previous quarter and by 81% YoY
The P/B is 95% more than the 5-year quarterly average of 1.2 and 67% more than the last 4 quarters average of 1.4
Angiodynamics's equity has decreased by 3.4% from the previous quarter and by 3.4% YoY
The P/S is 54% more than the last 4 quarters average of 2.3 and 48% more than the 5-year quarterly average of 2.4
The revenue has increased by 10% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Angiodynamics business performance
ANGO's ROIC has soared by 84% YoY and by 78% QoQ
The ROE has soared by 81% since the previous quarter and by 76% year-on-year
Angiodynamics's ROS has soared by 81% YoY and by 81% from the previous quarter
ANGO's ROA has soared by 81% since the previous quarter and by 78% year-on-year

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
ANGO's current ratio is down by 18% year-on-year and by 16% since the previous quarter
The quick ratio has decreased by 17% QoQ and by 13% YoY
The company's debt is 95% lower than its equity
The company's debt has shrunk by 50% YoY and by 33% QoQ
The debt to equity has contracted by 44% YoY and by 29% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.